Craig Chambliss of Neurelis Wins Entrepreneur Of The Year® 2026 National Overall Award

Craig Chambliss Wins Entrepreneur Of The Year Award



In an impressive display of entrepreneurial excellence, Craig Chambliss, the CEO and Co-Founder of Neurelis, has been recognized as the Entrepreneur Of The Year® 2026 National Overall Award winner by Ernst & Young LLP (EY US). This accolade highlights his significant contributions to the field of neuroscience and his commitment to developing critical therapies for conditions like epilepsy.

Background on Neurelis


Founded in 2007, Neurelis was established with a clear mission: to improve treatment modalities for individuals suffering from epilepsy and other neurological disorders. Chambliss's journey into the world of neuroscience began with a profound understanding of the challenges faced by patients. He recognized the limitations of existing treatments, particularly in how quickly they could be administered during a seizure. This realization sparked the idea to innovate how critical treatments reach patients in dire situations, transforming the way care is delivered in moments where every second counts.

Chambliss gathered a dedicated team and embarked on a mission to address longstanding issues in drug delivery and treatment accessibility for the epilepsy community. Over the years, Neurelis navigated numerous challenges, including complex formulation processes, clinical trials, and rigorous regulatory requirements.

Milestones and Achievements


A significant milestone was reached in 2020 when Neurelis secured FDA approval for its diazepam nasal spray, designed for managing seizure clusters effectively. This breakthrough not only marked a turning point for the company but also provided a vital solution for patients, including children as young as two years old, ensuring they have access to the necessary treatment at a critical moment.

Under Chambliss's visionary leadership, Neurelis has not only achieved remarkable business growth but has also stayed true to its core mission. The focus has always been on the lives impacted by their innovations, ensuring that patients and caregivers are at the heart of their endeavors. The recognition from EY underscores the transformative progress Neurelis has made, solidifying its position as a leader in the neuroscience industry.

The Award and Its Significance


This award is a celebration of entrepreneurial spirit, purpose, and impact, embodying the characteristics that Craig Chambliss epitomizes. EY’s Americas Entrepreneurship leader, Anna Horndahl, remarked on Chambliss's unique ability to envision possibilities amid challenges, stating that his leadership style exemplifies the essence of entrepreneurial impact in today’s economy. The award also places Chambliss among other distinguished winners who were recognized for their innovative contributions across various sectors, including consumer products, financial services, and technology.

Throughout the decades, the Entrepreneur Of The Year program has honored over 11,000 entrepreneurs who have made significant strides in reshaping industries and communities alike. With 209 regional winners from 184 companies being recognized this year, collectively generating over $78 billion in revenue, the breadth of the impact is monumental, showcasing how innovative ideas can lead to substantial economic growth and job creation.

Future Aspirations


Looking ahead, Chambliss and his team at Neurelis remain committed to expanding their reach and enhancing their product offerings to meet the evolving needs of neurological patients. The Entrepreneur Of The Year recognition places them within a distinguished network of like-minded leaders and innovators dedicated to creating lasting impacts in their fields. With continuous support through programs like EY’s Entrepreneurial Winning Women™ and the Entrepreneurs Access Network, Neurelis is poised to continue making a difference in the lives of individuals affected by neurological disorders.

As they move forward, the entrepreneurial community is excited to witness how Craig Chambliss and Neurelis will leverage this recognition to amplify their message and drive innovations that truly make a difference. The journey of transforming how care is delivered for those with epilepsy is far from over, and with Chambliss at the helm, the future looks promising.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.